RecallHawk
Class II Recall

AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg,

C & A Naturistics

Summary

The FDA issued a Class II for AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg, by C & A Naturistics. Reason: Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen..

Details

Source

Drug Recall

External ID

D-0024-2025

Action Date

2024-10-30

Status

Ongoing

Category

drug

Product Description

AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg,

Lot/Code Info: All Lots

Quantity Affected: Unknown

Reason for Recall

Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.

Distribution

Nationwide within the United States

Type: Voluntary: Firm initiated

Recall Initiated: 2024-10-08

Company

C & A Naturistics

National City, CA

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 37 drug recalls issued in the same week, part of 267 drug-related FDA actions this month.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (C & A Naturistics) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does C & A Naturistics have FDA actions?

This is the only FDA action we have on record for C & A Naturistics in our database.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "D-0024-2025" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions